Cargando…
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers
Comprehensive genomic profiling (CGP) tests have been covered by public insurance in Japan for patients with advanced solid tumors who have completed or are completing standard treatments or do not have them. Therefore, genotype‐matched drug candidates are often unapproved or off‐label, and improvin...
Autores principales: | Hagio, Kanako, Kikuchi, Junko, Takada, Kohichi, Tanabe, Hiroki, Sugiyama, Minako, Ohhara, Yoshihito, Amano, Toraji, Yuki, Satoshi, Komatsu, Yoshito, Osawa, Takahiro, Hatanaka, Kanako C., Hatanaka, Yutaka, Mitamura, Takashi, Yabe, Ichiro, Matsuno, Yoshihiro, Manabe, Atsushi, Sakurai, Akihiro, Ishiguro, Atsushi, Takahashi, Masato, Yokouchi, Hiroshi, Naruse, Hirohito, Mizukami, Yusuke, Dosaka‐Akita, Hirotoshi, Kinoshita, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394138/ https://www.ncbi.nlm.nih.gov/pubmed/37208840 http://dx.doi.org/10.1111/cas.15837 |
Ejemplares similares
-
Genetic heterogeneity during breast cancer progression in young patients
por: Hagio, Kanako, et al.
Publicado: (2021) -
Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer
por: Hagio, Kanako, et al.
Publicado: (2021) -
A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy
por: Takeuchi, Satoshi, et al.
Publicado: (2011) -
Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer
por: Mitamura, Takashi, et al.
Publicado: (2022) -
Role of targeted therapy in metastatic colorectal cancer
por: Ohhara, Yoshihito, et al.
Publicado: (2016)